BIOTECH · OpenAI buys Orchestra Bio to push deeper into drug R&D
The deal folds a four-year-old startup's drug-development AI agents into Rosalind, OpenAI's life-sciences model, as rival labs race into biotech.
Read the full story →
#Biotech #OpenAI #TheDailyFathom
BIOTECH · OpenAI buys Orchestra Bio to push deeper into drug R&D The deal folds a four-year-old startup's drug-development AI agents into Rosalind, OpenAI's life-sciences model, as rival labs race into biotech. Read the full story → #Biotech #OpenAI #TheDailyFathom
0 vue
Publié le 21/10/2026 12:10
0:24
BIOTECH · OpenAI buys Orchestra Bio to push deeper into drug R&D
The deal folds a four-year-old startup's drug-development AI agents into Rosalind, OpenAI's life-sciences model, as rival labs race into biotech.
Read the full story →
#Biotech #OpenAI #TheDailyFathom
0 commentaire
?